Search

Search Results

• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  https://doi.org/10.4081/reumatismo.2011.91

  1187

  PDF: 725
• 

  Voriconazole-induced periostitis

  D.C. Fernández Ávila, M. Diehl, A.M. Degrave, M. Buttazzoni, T. Pereira, M.A. Aguirre, A.L. Basquiera, M. Scolnik

  44-47

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1368

  3970

  PDF: 835

• Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

  S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

  22-27

  https://doi.org/10.4081/reumatismo.2008.22

  1154

  PDF: 945

• Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience

  C. Botsios, P. Ostuni, S. Todesco

  44-51

  https://doi.org/10.4081/reumatismo.2005.44

  1149

  PDF: 1728

• Treatment of Wegener’s granulomatosis

  V. Riccieri, G. Valesini

  69-76

  https://doi.org/10.4081/reumatismo.2004.69

  1316

  PDF: 5183

• Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience

  F. Giorgetti, M.L. Minnucci, P. Santori, L. Ercoli, M. Rossi, M. Del Papa, G. Morico, P. Squadroni, A. Olivieri, R. Centurioni

  51-56

  https://doi.org/10.4081/reumatismo.2004.51

  1157

  PDF: 1047
• 

  To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis

  Alessandro Tomelleri, Christian Dejaco, Milena Bond

  13-02-2025

  https://doi.org/10.4081/reumatismo.2025.1791

  965

  PDF: 20